What is United-Guardian Inc?
develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally.
UG · Verdict
Moderate reward · low risk
UG stands out on balance sheet and cash flow, but watch the growth signal.
Based on 88% data coverage
UG · Verdict
Current ratio 6.62
25% free-cash-flow margin
27% net margin · 18% ROE
Rev -4.4% CAGR · earnings -11.3%
Model-based scoring. For information only — not financial advice.
develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil is incorporated into a Lubrajel base. The company is listed on the NASDAQ in USA, operating in the Consumer Defensive sector, with a market capitalisation of 28.35M, and a P/E ratio of 14.3x.
The scoring profile indicates limited reward potential at this time, with profitability and valuation offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.